A Case of Steatocystoma Multiplex in a Psoriatic Patient During Treatment with Anti-IL-12/23

Overview

Journal Skin Appendage Disord

Specialty Dermatology

Date 2020 Oct 22

PMID 33088817

Citations 1

Authors

Claudio Marasca

Matteo Megna

Marianna Donnarumma

Giuseppina Fontanella

Eleonora Cinelli

Gabriella Fabbrocini

Affiliations

Soon will be listed here.

Abstract

Steatocystoma multiplex (SM) is an autosomal dominant disorder developing in adolescence or early adult age. The occurrence of multiple asymptomatic cutaneous cysts on the axillae, groin, trunk, and limbs characterizes the disease. SM is associated with a missense mutation in the keratin 17 gene (KRT17), a gene encoding for a type I intermediate filament (keratin 17 [K17]), mainly expressed in the epithelial appendages (hair follicles and sebaceous glands). Here, we report a case of appearance of multiple steatocystomas in a psoriatic patient during ustekinumab treatment, an interleukin (IL)-12/IL-23 inhibitor. Our hypothesis is that ustekinumab could have unmasked a potential genetic predisposition to SM by reducing the expression of interferon-γ and IL-17/IL-22 and consequently acting on the K17 pathway.

Citing Articles

Steatocystoma Multiplex.

Palaniappan V, Karthikeyan K Indian Dermatol Online J. 2024; 15(1):105-112.

PMID: 38283021 PMC: 10810380. DOI: 10.4103/idoj.idoj_490_23.

References

DePianto D, Kerns M, Dlugosz A, Coulombe P . Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin. Nat Genet. 2010; 42(10):910-4. PMC: 2947596. DOI: 10.1038/ng.665. View

Savage L, Wittmann M, McGonagle D, Helliwell P . Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis. Rheumatol Ther. 2016; 2(1):1-16. PMC: 4883251. DOI: 10.1007/s40744-015-0010-2. View

Yang L, Zhang S, Wang G . Keratin 17 in disease pathogenesis: from cancer to dermatoses. J Pathol. 2018; 247(2):158-165. DOI: 10.1002/path.5178. View

Tong X, Coulombe P . Keratin 17 modulates hair follicle cycling in a TNFalpha-dependent fashion. Genes Dev. 2006; 20(10):1353-64. PMC: 1472909. DOI: 10.1101/gad.1387406. View

Gilliet M, Lande R . Antimicrobial peptides and self-DNA in autoimmune skin inflammation. Curr Opin Immunol. 2008; 20(4):401-7. DOI: 10.1016/j.coi.2008.06.008. View

Zhang W, Dang E, Shi X, Jin L, Feng Z, Hu L . The pro-inflammatory cytokine IL-22 up-regulates keratin 17 expression in keratinocytes via STAT3 and ERK1/2. PLoS One. 2012; 7(7):e40797. PMC: 3396590. DOI: 10.1371/journal.pone.0040797. View

Zhang B, Sun L, Fu X, Yu G, Liu H, Zhang F . Mutation analysis of the KRT17 gene in steatocystoma multiplex and a brief literature review. Clin Exp Dermatol. 2019; 45(1):132-134. DOI: 10.1111/ced.14030. View

Kamra H, Gadgil P, Ovhal A, Narkhede R . Steatocystoma multiplex-a rare genetic disorder: a case report and review of the literature. J Clin Diagn Res. 2013; 7(1):166-8. PMC: 3576779. DOI: 10.7860/JCDR/2012/4691.2698. View

Guttman-Yassky E, Nograles K, Krueger J . Contrasting pathogenesis of atopic dermatitis and psoriasis--part I: clinical and pathologic concepts. J Allergy Clin Immunol. 2011; 127(5):1110-8. DOI: 10.1016/j.jaci.2011.01.053. View

10.

Lin K, Chang M, Ho W . Treatment of steatocystoma multiplex on axillae using keyhole approach technique. J Cosmet Laser Ther. 2018; 21(4):1. DOI: 10.1080/14764172.2018.1525746. View

11.

Jin L, Wang G . Keratin 17: a critical player in the pathogenesis of psoriasis. Med Res Rev. 2013; 34(2):438-54. DOI: 10.1002/med.21291. View